Skip to content
The Nexus
HEALTHJul 31 · 17:50 UTCQUARTZCris Tolomia

Rohto is recalling nearly 12 million eye drop bottles over sterility concerns

Rohto is recalling nearly 12 million eye drop bottles due to sterility concerns. The FDA classified the recall as Class II, indicating the products may cause temporary effects but are unlikely to result in serious harm.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting